TREE NEWS reports: AstraZeneca reported third-quarter core earnings per share of $2.79, beating the $2.62 consensus estimate. The pharmaceutical group’s quarterly result came in above analyst expectations.
AstraZeneca Q3 core EPS $2.79 vs $2.62 expected
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
4m ago
SF Holding Deputy GM and Board Secretary Gan Ling Resigns for Personal Reasons
7m ago
Jinzhongzi Liquor Narrows Nine-Month Loss to 98.55 Million Yuan
9m ago
New China Life posts Q3 net loss of 511 million yuan; nine-month profit down 32.2%
23m ago
European stocks open mixed as Stoxx 50 falls 0.61%
24m ago
Intel Falls Over 23% Premarket as Q4 Guidance Disappoints; Israel Plant Blast Adds to Woes
39m ago
Dizal Pharma Swings to 3.64B Yuan Profit in First Three Quarters of 2026